Europharmedtech SRL
1.2 FTEEuropharmedtech reported total assets of 54,960 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 1.2 full-time equivalent.
The score of Europharmedtech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -50 % Headcount (avg FTE) +9 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Europharmedtech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 23 Jun 2022
Europharmedtech's financial analysis
- Solvency-52.4%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Europharmedtech
Europharmedtech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0685.431.593
- VAT number
- BE0685431593
- Peppol
- Registered · 0208:0685431593 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Nov 2017
- Registered office
- 1083 Ganshoren
- Size
- Micro · 1.2 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Europharmedtech (SRL) has been based in Ganshoren since 2017, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 69,941 € and equity of −28,814 €; its revenue is not published. With 1.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -52.4%, below the median of its sector (45.7%).
Companies similar to Europharmedtech
Companies in the same business, of comparable size and area, outside its group.
- " Akontio " Research and experimental development on natural sciences and engineering Huy · balance sheet 69,650 €
- MDSH Research and experimental development on natural sciences and engineering Ixelles · balance sheet 92,229 €
- Biokey Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 2,606 €
- Biograbbit Research and experimental development on natural sciences and engineering Dendermonde · balance sheet 61,503 €
- Allsightsafrica Research and experimental development on natural sciences and engineering Orp-Jauche · balance sheet 30,275 €
- Herlinco Accounting, bookkeeping and auditing activities; tax consultancy Overijse · balance sheet 109,375 €
- Shift Happens Research and experimental development on natural sciences and engineering Ghent · balance sheet 62,809 €
- Immther Research and experimental development on natural sciences and engineering Oud-Heverlee · balance sheet 25,533 €
Frequently asked questions about Europharmedtech
What is the revenue of Europharmedtech?
Europharmedtech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Europharmedtech?
In Belgium, the VAT number is the company number prefixed with BE: BE0685431593 for Europharmedtech, if the company is VAT-registered. Its company number (CBE) is 0685.431.593.
Where is the registered office of Europharmedtech?
According to the CBE register, the registered office of Europharmedtech is in 1083 Ganshoren.
What is the equity of Europharmedtech?
At the close of the 2025 financial year, the equity of Europharmedtech amounts to -28,814 €, a solvency of -52.4% of total assets.
How many people work at Europharmedtech?
1.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Europharmedtech?
The register lists 2 active mandates at Europharmedtech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Europharmedtech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →